Filtered By:
Vaccination: Covid Vaccine
This page shows you your search results in order of date. This is page number 20.
Order by Relevance | Date
Total 26665 results found since Jan 2013.
Psoriatic Arthritis And Covid-19 - Patient Perspectives In A Large Psoriatic Arthritis Cohort
CONCLUSION: COVID-19 prevalence was low among our patients. Patients were satisfied with their care during the pandemic. Most patients would happily continue with virtual care for the duration of the pandemic.PMID:37657794 | DOI:10.3899/jrheum.2022-1265
Source: J Rheumatol - September 1, 2023 Category: Rheumatology Authors: Neda Pirouzmand Daniel Pereira Mitchell Sutton Ashish J Mathew Vinod Chandran Dafna D Gladman Source Type: research
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort
EClinicalMedicine. 2023 Jul 21;62:102107. doi: 10.1016/j.eclinm.2023.102107. eCollection 2023 Aug.ABSTRACTBACKGROUND: Lack of specific definitions of clinical characteristics, disease severity, and risk and preventive factors of post-COVID-19 syndrome (PCS) severely impacts research and discovery of new preventive and therapeutics drugs.METHODS: This prospective multicenter cohort study was conducted from February 2020 to June 2022 in 5 countries, enrolling SARS-CoV-2 out- and in-patients followed at 3-, 6-, and 12-month from diagnosis, with assessment of clinical and biochemical features, antibody (Ab) response, Variant o...
Source: Cell Research - September 1, 2023 Category: Cytology Authors: Elisa Gentilotti Anna G órska Adriana Tami Roy Gusinow Massimo Mirandola Jes ús Rodríguez Baño Zaira R Palacios Baena Elisa Rossi Jan Hasenauer Iris Lopes-Rafegas Elda Righi Natascia Caroccia Salvatore Cataudella Zeno Pasquini Thomas Osmo Lidia Del Pi Source Type: research
Psoriatic Arthritis And Covid-19 - Patient Perspectives In A Large Psoriatic Arthritis Cohort
CONCLUSION: COVID-19 prevalence was low among our patients. Patients were satisfied with their care during the pandemic. Most patients would happily continue with virtual care for the duration of the pandemic.PMID:37657794 | DOI:10.3899/jrheum.2022-1265
Source: J Rheumatol - September 1, 2023 Category: Rheumatology Authors: Neda Pirouzmand Daniel Pereira Mitchell Sutton Ashish J Mathew Vinod Chandran Dafna D Gladman Source Type: research
RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges
Adv Drug Deliv Rev. 2023 Aug 30:115073. doi: 10.1016/j.addr.2023.115073. Online ahead of print.ABSTRACTThe era of RNA medicine has become a reality with the success of messenger RNA (mRNA) vaccines against COVID-19 and the approval of several RNA interference (RNAi) agents in recent years. Particularly, therapeutics based on RNAi offer the promise of targeting intractable and previously undruggable disease genes. Recent advances have focused in developing delivery systems to enhance the poor cellular uptake and insufficient pharmacokinetic properties of RNAi therapeutics and thereby improve its efficacy and safety. However...
Source: Advanced Drug Delivery Reviews - September 1, 2023 Category: Drugs & Pharmacology Authors: Jong Won Lee Man Kyu Shim Hyosuk Kim Hochung Jang Yuhan Lee Sun Hwa Kim Source Type: research
Psoriatic Arthritis And Covid-19 - Patient Perspectives In A Large Psoriatic Arthritis Cohort
CONCLUSION: COVID-19 prevalence was low among our patients. Patients were satisfied with their care during the pandemic. Most patients would happily continue with virtual care for the duration of the pandemic.PMID:37657794 | DOI:10.3899/jrheum.2022-1265
Source: J Rheumatol - September 1, 2023 Category: Rheumatology Authors: Neda Pirouzmand Daniel Pereira Mitchell Sutton Ashish J Mathew Vinod Chandran Dafna D Gladman Source Type: research
Factors that impact on recruitment to vaccine trials in the context of a pandemic or epidemic: a qualitative evidence synthesis
CONCLUSIONS: This review identifies many of the factors that influence a person's decision to take part in a vaccine trial, and these reflect findings from reviews that examine trials more broadly. However, we also recognise some factors that become more important in connection with a vaccine trial in the context of a pandemic or epidemic. These factors include the potential stigma of taking part, the possible adverse effects of a vaccine, the added motivation for helping society, the role of community leaders in trial dissemination, and the level of trust placed in governments and companies developing vaccines. These spec...
Source: Cochrane Database of Systematic Reviews - September 1, 2023 Category: General Medicine Authors: Pauline Meskell Linda M Biesty Maura Dowling Kevin Roche Elaine Meehan Claire Glenton Declan Devane Sasha Shepperd Andrew Booth Rebecca Cox Xin Hui S Chan Catherine Houghton Source Type: research
Psoriatic Arthritis And Covid-19 - Patient Perspectives In A Large Psoriatic Arthritis Cohort
CONCLUSION: COVID-19 prevalence was low among our patients. Patients were satisfied with their care during the pandemic. Most patients would happily continue with virtual care for the duration of the pandemic.PMID:37657794 | DOI:10.3899/jrheum.2022-1265
Source: J Rheumatol - September 1, 2023 Category: Rheumatology Authors: Neda Pirouzmand Daniel Pereira Mitchell Sutton Ashish J Mathew Vinod Chandran Dafna D Gladman Source Type: research
Canada's National Advisory Committee on immunization: Adaptations and challenges during the COVID-19 pandemic
Vaccine. 2023 Aug 30:S0264-410X(23)00991-X. doi: 10.1016/j.vaccine.2023.08.048. Online ahead of print.ABSTRACTThe COVID-19 pandemic has challenged traditional vaccine guidance infrastructure and frameworks, and added urgency and complexity to the operation of National Immunization Technical Advisory Groups (NITAGs). Canada's National Advisory Committee on Immunization (NACI) provides immunization guidance to the Public Health Agency of Canada (PHAC) who publicly shares expert and evidence-informed guidance with Canadian provinces and territories. Throughout the pandemic, NACI and PHAC implemented many adaptations to meet u...
Source: Vaccine - September 1, 2023 Category: Allergy & Immunology Authors: Matthew Tunis Shelley Deeks Robyn Harrison Caroline Quach Shainoor Ismail Marina Salvadori Bryna Warshawsky Kelsey Young Christine Mauviel Erin Henry Source Type: research
Challenges in Estimating Effectiveness of 2 Doses of COVID-19 Vaccines Beyond 6 Months in England
Am J Epidemiol. 2023 Sep 1:kwad179. doi: 10.1093/aje/kwad179. Online ahead of print.NO ABSTRACTPMID:37656609 | DOI:10.1093/aje/kwad179
Source: Am J Epidemiol - September 1, 2023 Category: Epidemiology Authors: Elsie M F Horne William J Hulme Ruth H Keogh Tom M Palmer Elizabeth J Williamson Edward P K Parker Venexia M Walker Rochelle Knight Yinghui Wie Kurt Taylor Louis Fisher Jessica Morley Amir Mehrkar Iain Dillingham Sebastian Bacon Ben Goldacre Jonathan A C Source Type: research
Factors that impact on recruitment to vaccine trials in the context of a pandemic or epidemic: a qualitative evidence synthesis
CONCLUSIONS: This review identifies many of the factors that influence a person's decision to take part in a vaccine trial, and these reflect findings from reviews that examine trials more broadly. However, we also recognise some factors that become more important in connection with a vaccine trial in the context of a pandemic or epidemic. These factors include the potential stigma of taking part, the possible adverse effects of a vaccine, the added motivation for helping society, the role of community leaders in trial dissemination, and the level of trust placed in governments and companies developing vaccines. These spec...
Source: Cochrane Database of Systematic Reviews - September 1, 2023 Category: General Medicine Authors: Pauline Meskell Linda M Biesty Maura Dowling Kevin Roche Elaine Meehan Claire Glenton Declan Devane Sasha Shepperd Andrew Booth Rebecca Cox Xin Hui S Chan Catherine Houghton Source Type: research
Canada's National Advisory Committee on immunization: Adaptations and challenges during the COVID-19 pandemic
Vaccine. 2023 Aug 30:S0264-410X(23)00991-X. doi: 10.1016/j.vaccine.2023.08.048. Online ahead of print.ABSTRACTThe COVID-19 pandemic has challenged traditional vaccine guidance infrastructure and frameworks, and added urgency and complexity to the operation of National Immunization Technical Advisory Groups (NITAGs). Canada's National Advisory Committee on Immunization (NACI) provides immunization guidance to the Public Health Agency of Canada (PHAC) who publicly shares expert and evidence-informed guidance with Canadian provinces and territories. Throughout the pandemic, NACI and PHAC implemented many adaptations to meet u...
Source: Vaccine - September 1, 2023 Category: Allergy & Immunology Authors: Matthew Tunis Shelley Deeks Robyn Harrison Caroline Quach Shainoor Ismail Marina Salvadori Bryna Warshawsky Kelsey Young Christine Mauviel Erin Henry Source Type: research
